Mark Ragosa - Net Worth and Insider Trading
Mark Ragosa Net Worth
The estimated net worth of Mark Ragosa is at least $471,506 dollars as of 2024-09-13. Mark Ragosa is the CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 19,253 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $471,506. Details can be seen in Mark Ragosa's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Ragosa has not made any transactions after 2024-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Ragosa
Mark Ragosa Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Ragosa owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .
Click here to see the complete history of Mark Ragosa’s form 4 insider trades.
Insider Ownership Summary of Mark Ragosa
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2024-07-23 | Interim CFO |
Mark Ragosa Latest Holdings Summary
Mark Ragosa currently owns a total of 1 stock. Mark Ragosa owns 19,253 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of July 23, 2024, with a value of $471,506.
Latest Holdings of Mark Ragosa
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2024-07-23 | 19,253 | 24.49 | 471,506 |
Holding Weightings of Mark Ragosa
Mark Ragosa Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Ragosa has made a total of 1 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 24,248 shares on July 23, 2024, which brought Mark Ragosa around $601,108.
Insider Trading History of Mark Ragosa
- 1
Mark Ragosa Trading Performance
Mark Ragosa Ownership Network
Mark Ragosa Owned Company Details
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
Mark Ragosa is the Interim CFO of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Group VP & Rilonacept GM Ross Moat , Chief Medical Officer John Paolini , and Chief Business Officer Eben Tessari .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, Mark Ragosa made 1 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 24,248. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 219,460 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 329,070 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 329,070 shares. During the past 18 months, 504,663 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 504,663 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
Mark Ragosa Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Ragosa. You might contact Mark Ragosa via mailing address: C/o Kiniksa Pharmaceuticals Corp., 100 Hayden Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
